24 results
8-K
EX-4.2
ALGS
Aligos Therapeutics Inc
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
as reported by Bloomberg Financial Markets (or a comparable reporting service of national reputation selected by the Company and reasonably acceptable
424B4
nr2sd0c
1 Jul 21
Prospectus supplement with pricing info
4:31pm
DRS
rg8dz m8w5nf6jc42jwq
4 Jun 21
Draft registration statement
12:00am
10-K
kdvwy5u
23 Mar 21
Annual report
4:26pm
10-Q
gd5tcz90av 0vlc
25 Nov 20
Quarterly report
5:21pm
424B4
hwbcrqfjedb2jfmc4foi
19 Oct 20
Prospectus supplement with pricing info
5:21pm